The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
about
Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancerThe interplay of extracellular matrix and microbiome in urothelial bladder cancer.CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).RHAMM splice variants confer radiosensitivity in human breast cancer cell linesExpression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck.Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.Targeted therapies in bladder cancer: an overview of in vivo research.Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.Increased RHAMM expression relates to ovarian cancer progression.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Prognostic significance of receptor for hyaluronan acid-mediated motility (CD168) in acute pediatric leukemias - assessment of clinical outcome, post induction, end of treatment and minimal residual disease
P2860
Q35040383-F85A31AA-F7CB-4472-AFD3-1781A56687D0Q35868405-566B9FEC-2C8D-45F8-8161-FDC97CF6B380Q36123305-CA0B18DD-9C14-47D4-97C1-7E695EAC63CBQ37225307-F7763596-10A3-4CF1-8A2F-2245A2D2CB60Q37457741-A841ABD2-EBC4-4959-AD6E-6C3D25D7CB51Q37731962-6FE0343B-ED26-4810-B3ED-C37D96705A69Q38199975-7E23405D-8C07-435C-A665-CBDE19266080Q38590471-F361216E-3464-4AB7-8DC2-91FEBFCCD945Q38796290-C9B3ABD0-F81B-4472-9B1E-44EC871E35BFQ40986079-D3440641-C995-4D33-A732-05B5C864CC04Q41770223-BEF41CAF-6988-44CA-A640-966F1C00DF5AQ47281580-B95795E6-1627-4AE3-A1F4-26D1C2DF571CQ58124882-041E7E9C-F8F0-4F28-86F8-8AC88F3F3023
P2860
The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The impact of the receptor of ...... al cell cancer of the bladder.
@ast
The impact of the receptor of ...... al cell cancer of the bladder.
@en
The impact of the receptor of hyaluronan-mediated motility
@nl
type
label
The impact of the receptor of ...... al cell cancer of the bladder.
@ast
The impact of the receptor of ...... al cell cancer of the bladder.
@en
The impact of the receptor of hyaluronan-mediated motility
@nl
prefLabel
The impact of the receptor of ...... al cell cancer of the bladder.
@ast
The impact of the receptor of ...... al cell cancer of the bladder.
@en
The impact of the receptor of hyaluronan-mediated motility
@nl
P2093
P2860
P1433
P1476
The impact of the receptor of ...... al cell cancer of the bladder.
@en
P2093
Ariane Melchior-Becker
Christian Niedworok
Frank Vom Dorp
Herbert Rübben
Inga Kretschmer
Jens W Fischer
Jochen Heß
Katharina Röck
Tibor Szarvas
Till Freudenberger
P2860
P304
P356
10.1371/JOURNAL.PONE.0075681
P407
P577
2013-09-17T00:00:00Z